Immutep Ltd Share Price Today: Live Updates & Key Insights
Immutep Ltd share price today is $0.3921, up -4.34%. The stock opened at $0.3941 against the previous close of $0.4126, with an intraday high of $0.3991 and low of $0.3764.
Immutep Ltd Share Price Chart
Immutep Ltd
Immutep Ltd Share Price Performance
Immutep Ltd Institutional Holdings
Immutep Ltd Market Status
Immutep Ltd Fundamentals
Market Cap 58.17 M
PB Ratio 0.8649
PE Ratio 0.0
Enterprise Value -16.18 M
Total Assets 156.98 M
Volume 1439280
Immutep Ltd Company Financials
About Immutep Ltd & investment objective
Company Information Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.
Organisation Biotechnology
Employees 0
Industry Biotechnology
CEO Mr. Marc Voigt
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Immutep Ltd FAQs
What is the share price of Immutep Ltd today?
The current share price of Immutep Ltd is $0.3921.
Can I buy Immutep Ltd shares in India?
Yes, Indian investors can buy Immutep Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Immutep Ltd shares in India?
You can easily invest in Immutep Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Immutep Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Immutep Ltd.
Can I buy fractional shares of Immutep Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Immutep Ltd?
Immutep Ltd has a market cap of $58.17 M.
In which sector does Immutep Ltd belong?
Immutep Ltd operates in the Biotechnology sector.
What documents are required to invest in Immutep Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Immutep Ltd?
The PE ratio of Immutep Ltd is N/A and the PB ratio is 0.86.